Latest News

biotech radar UNIVERSE

Companies Covered (Core Coverage & Extra Coverage)

Company Visual Identity Country Listing Coverage Level
AB Science France Euronext Paris Core
ABIVAX France Euronext Paris Core
Acacia Pharma UK Euronext Brussels Core
Adocia France Euronext Paris Core
Advicenne France Euronext Paris Core
arGEN-X Netherlands Euronext Brussels Core
ASIT biotech Belgium Euronext Brussels Core
Biophytis France Euronext Paris Core
Bone Therapeutics Belgium Euronext Brussels Core
Cellectis France Euronext Paris Core
Celyad Belgium Euronext Brussels Core
Abionyx France Euronext Paris Core
Crossject France Euronext Paris Core
DBV Technologies France Euronext Paris Core
Erytech Pharma France Euronext Paris Core
Galapagos Belgium Euronext Brussels Core
GeNeuro Switzerland Euronext Paris Core
Genfit France Euronext Paris Core
Genkyotex Switzerland Euronext Paris Core
GenSight Biologics France Euronext Paris Core
Hybrigenics France Euronext Paris Core
Innate Pharma France Euronext Paris Core
Inventiva France Euronext Paris Core
Kiadis Pharma Netherlands Euronext Amsterdam Core
Lysogene France Euronext Paris Core
MedinCell France Euronext Paris Core
Mithra Pharma. Belgium Euronext Brussels Core
Nanobiotix France Euronext Paris Core
Neovacs France Euronext Paris Core
Nicox France Euronext Paris Core
Noxxon Germany Euronext Paris Core
Oncodesign France Euronext Paris Core
Onxeo France Euronext Paris Core
OSE Immunother. France Euronext Paris Core
Pharming Group Netherlands Euronext Amsterdam Core
Pharnext France Euronext Paris Core
Poxel France Euronext Paris Core
Vivoryon Germany Euronext Amsterdam Core
Quantum Genomics France Euronext Paris Core
Sensorion France Euronext Paris Core
Theranexus France Euronext Paris Core
Oxurion Belgium Euronext Brussels Core
Transgene France Euronext Paris Core
Valneva France Euronext Paris Core
4SC Germany Deutsche Börse Xetra® Frankfurt Core
Biofrontera Germany Deutsche Börse Xetra® Frankfurt Core
co.don Germany Deutsche Börse Xetra® Frankfurt Core
CytoTools Germany Deutsche Börse Xetra® Frankfurt Core
Evotec Germany Deutsche Börse Xetra® Frankfurt Core
Formycon Germany Deutsche Börse Xetra® Frankfurt Core
Heidelberg Pharma Germany Deutsche Börse Xetra® Frankfurt Core
Medigene Germany Deutsche Börse Xetra® Frankfurt Core
Mologen Germany Deutsche Börse Xetra® Frankfurt Core
Morphosys Germany Deutsche Börse Xetra® Frankfurt Core
Paion Germany Deutsche Börse Xetra® Frankfurt Core
Addex Therapeutics Switzerland SIX Swiss Exch. Zurich Core
Basilea Pharma. Switzerland SIX Swiss Exch. Zurich Core
Cassiopea Italy SIX Swiss Exch. Zurich Core
Cosmo Pharma. Italy SIX Swiss Exch. Zurich Core
Idorsia Switzerland SIX Swiss Exch. Zurich Core
Molecular Partners Switzerland SIX Swiss Exch. Zurich Core
Newron Pharma. Italy SIX Swiss Exch. Zurich Core
ObsEva Switzerland SIX Swiss Exch. Zurich Core
Polyphor Switzerland SIX Swiss Exch. Zurich Core
Santhera Switzerland SIX Swiss Exch. Zurich Core
4D Pharma UK London Stock Exch. / AIM Extra
Allergy Therapeutics UK London Stock Exch. / AIM Extra
Amryt Pharma Ireland London Stock Exch. / AIM Extra
Avacta UK London Stock Exch. / AIM Extra
Destiny Pharma UK London Stock Exch. / AIM Extra
Diurnal Group UK London Stock Exch. / AIM Extra
Evgen Pharma UK London Stock Exch. / AIM Extra
Hemogenyx Pharma. UK London Stock Exch. / AIM Extra
Immupharma UK London Stock Exch. / AIM Extra
Indivior UK London Stock Exch. / AIM Extra
Mereo BioPharma UK London Stock Exch. / AIM Extra
Midatech Pharma UK London Stock Exch. / AIM Extra
Motif Bio UK London Stock Exch. / AIM Extra
N4 Pharma UK London Stock Exch. / AIM Extra
Nuformix UK London Stock Exch. / AIM Extra
Okyo Pharma UK London Stock Exch. / AIM Extra
Oxford Biomedica UK London Stock Exch. / AIM Extra
Puretech Health UK London Stock Exch. / AIM Extra
Redx Pharma UK London Stock Exch. / AIM Extra
ReNeuron UK London Stock Exch. / AIM Extra
Sareum UK London Stock Exch. / AIM Extra
Scancell UK London Stock Exch. / AIM Extra
Shield Therapeutics UK London Stock Exch. / AIM Extra
Silence Therapeutics UK London Stock Exch. / AIM Extra
Summit Therapeutics UK London Stock Exch. / AIM Extra
Synairgen UK London Stock Exch. / AIM Extra
Tiziana Life Sciences UK London Stock Exch. / AIM Extra
ValiRx UK London Stock Exch. / AIM Extra
Verona Pharma UK London Stock Exch. / AIM Extra
Faron Pharma. Finland London Stock Exch. / AIM Extra
Bavarian Nordic Denmark Nasdaq OMX Copenhagen / Nordic List Extra
Genmab Denmark Nasdaq OMX Copenhagen / Nordic List Extra
Nuevolution Denmark Nasdaq OMX Stockholm / First North Extra
Oncology Venture Denmark Nasdaq OMX Stockholm / Nordic List Extra
Orphazyme Denmark Nasdaq OMX Copenhagen / Nordic List Extra
Saniona Denmark Nasdaq OMX Stockholm / Nordic List Extra
Zealand Pharma Denmark Nasdaq OMX Copenhagen / Nordic List Extra
Camurus Sweden Nasdaq OMX Stockholm / Nordic List Extra
Hansa Biopharma Sweden Nasdaq OMX Stockholm / Nordic List Extra
Oncopeptides Sweden Nasdaq OMX Stockholm / Nordic List Extra
Alligator Bioscience Sweden Nasdaq OMX Stockholm / Nordic List Extra
Alzinova Sweden Nasdaq OMX Stockholm / First North Extra
Medivir Sweden Nasdaq OMX Stockholm / Nordic List Extra
Orexo Sweden Nasdaq OMX Stockholm / Nordic List Extra
Oasmia Pharma. Sweden Nasdaq OMX Stockholm / Nordic List Extra
Active Biotech Sweden Nasdaq OMX Stockholm / Nordic List Extra
BioInvent Internat. Sweden Nasdaq OMX Stockholm / Nordic List Extra
NeuroVive Sweden Nasdaq OMX Stockholm / Nordic List Extra
Immunicum Sweden Nasdaq OMX Stockholm / Nordic List Extra
BioArctic Sweden Nasdaq OMX Stockholm / Nordic List Extra
Calliditas Ther. Sweden Nasdaq OMX Stockholm / Nordic List Extra
IRLAB Therapeutics Sweden Nasdaq OMX Stockholm / First North Extra
PledPharma Sweden Nasdaq OMX Stockholm / First North Extra
InDex Pharma Sweden Nasdaq OMX Stockholm / First North Extra
Kancera Sweden Nasdaq OMX Stockholm / First North Extra
Klaria Pharma Sweden Nasdaq OMX Stockholm / First North Extra
Vicore Pharma Sweden Nasdaq OMX Stockholm / First North Extra
Infant Bacterial Ther. Sweden Nasdaq OMX Stockholm / First North Extra
Sprint Bioscience Sweden Nasdaq OMX Stockholm / First North Extra
Diamyd Medical Sweden Nasdaq OMX Stockholm / First North Extra
Cantargia Sweden Nasdaq OMX Stockholm / First North Extra
Karessa Pharma Sweden Nasdaq OMX Stockholm / First North Extra
Corline Biomedical Sweden Nasdaq OMX Stockholm / First North Extra
Lidds Sweden Nasdaq OMX Stockholm / First North Extra
Xintela Sweden Nasdaq OMX Stockholm / First North Extra
Cyxone Sweden Nasdaq OMX Stockholm / First North Extra
Isofol Medical Sweden Nasdaq OMX Stockholm / First North Extra
XSpray Pharma Sweden Nasdaq OMX Stockholm / First North Extra
Promore Pharma Sweden Nasdaq OMX Stockholm / First North Extra
Annexin Pharma. Sweden Nasdaq OMX Stockholm / First North Extra
Guard Therapeutics Sweden Nasdaq OMX Stockholm / First North Extra
Gabather Sweden Nasdaq OMX Stockholm / First North Extra
XBrane Biopharma Sweden Nasdaq OMX Stockholm / First North Extra
Asarina Pharma Sweden Nasdaq OMX Stockholm / First North Extra
Alzecur Pharma Sweden Nasdaq OMX Stockholm / First North Extra
Combigene Sweden Nasdaq OMX Stockholm / First North Extra
Ascelia Pharma Sweden Nasdaq OMX Stockholm / First North Extra
Herantis Pharma Finland Nasdaq OMX Stockholm / First North Extra
BergenBio Norway Oslo Bors/Axess Extra
Nordic Nanovector Norway Oslo Bors/Axess Extra
PCI Biotech Norway Oslo Bors/Axess Extra
Targovax Norway Oslo Bors/Axess Extra
Ultimovacs Norway Oslo Bors/Axess Extra
Oryzon Genomics Spain Bolsa de Madrid BME Extra
Pharma Mar Spain Bolsa de Madrid BME Extra
Molmed Italy Borsa Italiana Milan Extra
Last Update 02/02/2020


Deal Monitor – European Public Biotech Companies

Data as of 14/02/2020.


Financing Monitor – European Public Biotech Companies

Data as of 14/02/2020.

DATA & INTEL FOR A 360° View on the Public biotech Landscape in europe

How We Help Investors & Professionals in Life Sciences
DISCOVER NEW COMPANIES WITH OUR BROAD COVERAGE

Our data coverage is focused on the European biotech companies listed on the main stock exchange platforms in 12 countries: Germany, France, Belgium, Netherlands, Switzerland, UK, Spain, Italy and the Nordic countries. The coverage only includes biotech companies developping therapeutics, we DO NOT COVER: pharma companies, the medtech landscape, nor the associated service companies (CRO, CMO, Drug Discovery, etc…), with few exceptions nevertheless. We include some potentially high-growth companies in the field of diagnostics, as well as some specialty companies.

ACCESS INSIGHTS, GAIN TIME, SPOT OPPORTUNITIES

We provide timely detailed data on the pipeline of all the companies, representing more than 1200 programs currently at the clinical stage (more than 2000 programs overall). Our service is both a discovery tool for potential new opportunities, and a platform tracking any event from the covered companies. It may also be seen as a promoting support for this universe, even though we are completely independent. Maximize knowledge in a short period, and gain a tremendous amount of time in your due dilligence and research process. We do not cover the scientific analysis part (results from clinical trials).

FINANCIAL DATA, MARKET DATA, DEALS, FINANCINGS…

We provide up-to-date relevant financial data on the companies: cash positions, cash burn rates, live cash estimates, cash runways, income statements. Don’t get lost in the numerous financing schemes with our detailed tracking of the financing lines (as much as decently possible). Access our database of financing agreements back up to 2010 on many covered companies, parse our records of the various partenerships between the companies and third parties. Keep track of the stocks on our free dashboards (disclaimers apply), and more.

INDICATORS AND ANALYTICS (IN DEVELOPMENT)

We will strive to deliver specific insights on the public European biotech landscape by leveraging our large -and still growing- set of data. We aim to provide intelligence, highlighting dynamics, as well as identifying trends in various relevant areas. We will also provide a picture of the landscape periodically. Some analysis may be published in the form of reports, reserved to our clients or made public. We will also develop indicators thought to be specifically relevant for investors.


Data from 13 Countries, 10 Languages, 8 Trading Platforms, 7 Currencies

Check out our introductory review

2018 Review European Biotech

Biotech Radar Service

All in one place, for PROs only
biotechradar.eu,
European hub for investors and professionnals
in Life Sciences

Our Service covers 100% of the pipeline & financial data of the European public biotech companies.
For the broader set of data, the Service currently has 2 main levels of Coverage: the Core Coverage, with the most extended set including history, and the Extra Coverage, with a less extended set and only including the most recent records (complete list of companies below).
The Core Coverage includes more than 40% of the public European biotech companies to date (main European stock markets only), represents more than 60% of the active programs at the clinical stage, and weights more than 60% of the total market capitalization out of our whole Universe. More than 70% of turnovers are concentrated on companies from the Core Coverage.
The market data can be accessed for free.
Through our Service, we strive to bring value to our clients, also indirectly showcasing this segment of the Biotech landscape at the same time.
We DO NOT provide any recommendations on any financial instruments. We own our data and we collect them from corporate or well-trusted sources (e.g. clinicaltrials.gov). We operate as an independent company.

  • Pipeline

    All the programs, all the product candidates & all the commercial products

  • Financials

    All the main financial figures

  • Total Turnovers

    on the Core Coverage

  • Active Clinical Programs & market capitalization

    on the Core Coverage

error: